Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, was named to Outsell, Inc.'s "10 to Watch" list for the Market Research, Reports & Services segment. Outsell's new report entitled Market Research and IT & Telecom Research, Reports & Services: 2009 Market Forecast and Trends Report finds that Decision Resources, Inc.'s growth is a combination of acquisitions and expansion of new and existing product lines.

"Decision Resources, Inc.'s significant growth in 2008 came from its acquisitions of Fingertip Formulary, Arlington Medical Resources and portions of Wood Mackenzie's Life Sciences business," said Louise Garnett, vice president and lead analyst for Outsell, Inc. (www.outsellinc.com). "In April 2009, the company also announced availability of DecisionBase 2009, which was expanded to include surveys of both U.S. and European physician specialists. The combination of the company's acquisition momentum and its growth of current product lines lands Decision Resources, Inc. on our '10 To Watch' list."

Decision Resources, Inc. also moved up significantly in this year's Inc. Magazine's Inc. 5000 list. Inc. Magazine placed Decision Resources, Inc. at #2046 in the 2009 list (in 2008 the company came in at #3422).

"Our growth strategy centers around the guiding principle of offering innovative market research and high-value analytics to the healthcare industry," said Peter Hoenigsberg, CEO of Decision Resources, Inc. "This is realized through strategic acquisitions of organizations like Fingertip Formulary and Manhattan Research and through strong growth of existing product lines consistent with the needs of our clients."

About Decision Resources

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

  All company, brand, or product names contained in this document may be      trademarks or registered trademarks of their respective holders.     For more information, contact:    Elizabeth Marshall   Decision Resources, Inc.   781-296-2563   emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018

View Now